Shilpa Medicare Q2 Results
- BSE: 530549
- NSE: SHILPAMED
- ISIN: INE790G01031
- Sector: Biotechnology & Drugs
BSE
422.00
2.85 (0.68%)
2.85 (0.68%)Volume14.72 K
Updated: Fri 10 Apr, 2026 | 15:29:10
NSE
420.101.10 (0.26%)
1.10 (0.26%)Volume3.60 L
Updated: Fri 10 Apr, 2026 | 15:41:36
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Shilpa Medicare Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 291.51 | 258.74 | 12.66% | 286.07 | 1.90% |
| Depreciation/ Amortization | 29.82 | 28.92 | 3.12% | 28.28 | 5.44% |
| Operating Income | 78.46 | 62.72 | 25.10% | 57.72 | 35.92% |
| Net Income | 44.07 | 46.89 | -6.01% | 17.94 | 145.67% |
| Other Operating Expenses Total | 73.14 | 68.40 | 6.93% | 59.65 | 22.62% |
| Net Income Before Taxes | 64.43 | 49.58 | 29.95% | 36.77 | 75.22% |
| Total Revenue | 369.97 | 321.46 | 15.09% | 343.80 | 7.61% |
| Selling/ General/ Admin Expenses Total | 83.05 | 81.81 | 1.51% | 76.16 | 9.05% |
| Diluted Normalized EPS | 2.25 | 2.40 | -5.92% | 0.93 | 142.27% |